Skip to main content
NIH funding notice PAR-19-334

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed

Closed on July 9, 2020.

Posted
August 5, 2019
Close date
July 9, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,741,115 in first-year total cost, median $250,000.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IDM-V (12)]2
  2. Special Emphasis Panel[ZRG1 IMST-H (15)]2
  3. Special Emphasis Panel[ZRG1 ETTN-C (19)]1
  4. Special Emphasis Panel[ZRG1 IMST-K (14)]1
  5. Special Emphasis Panel[ZRG1 RPHB-Y (19)]1

Most frequent institutions

  1. EYENUK, INC.1
  2. IMCARE BIOTECH, INC.1
  3. IQ MEDICAL IMAGING, LLC1
  4. MICROVI BIOTECH, INC.1
  5. O-RAY PHARMA, INC.1
Competing awards under PAR-19-334 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021MDCT Quantification of hepatic tumor viability for assessment of cancer therapy2SB1CA189637-04WU, YINIQ MEDICAL IMAGING, LLC, MA$240,583ZRG1
2021An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion.2SB1CA210696-04LAUB, GLENN WWILKIE, JAMES ATDL INNOVATIONS, LLC, NJ$199,347ZRG1
2021Comprehensive Intellectual Property, Reimbursement, and Licensing Strategy for ImCare Biotech's Diagnostic Product Seravue2SB1CA165314-05A1LU, XUANYONGIMCARE BIOTECH, INC., PA$166,729ZRG1
2020High-throughput Biocatalyst Manufacturing for Environmental Biotechnology2R44ES024670-04SHIRAZI, FATEMEHMICROVI BIOTECH, INC., CA$300,000ZRG1
2020Automated image-based biomarker computation tools for diabetic retinopathy2SB1TR000377-07SOLANKI, KAUSHALEYENUK, INC., CA$300,000ZRG1
2020Prevention of Children's Tympanostomy Tube Otorrhea2R44DC014416-04KU, MATTHEWSLATTERY, WILLIAM HO-RAY PHARMA, INC., CA$284,456ZRG1
2020Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN.2SB1CA213555-04MIZISIN, ANDREWWINSANTOR, INC., CA$250,000ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-334: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed | ScienceDex | ConductScience